Pharma & Biotech

Redcare Pharmacy finds itself grappling with a severe crisis of confidence among investors. The company's stock has shed more than...

Investor optimism for a breakthrough Alzheimer's treatment from Novo Nordisk has evaporated following disappointing clinical trial results. The pharmaceutical giant's...

Investor attention is sharply focused on today's CureVac shareholder meeting, which represents a critical juncture for BioNTech. The assembly will...

Investors in InnoCan Pharma faced a brutal trading session on Monday as the company's stock plummeted approximately 16% during European...

A coordinated assault by international hedge funds is placing significant downward pressure on Redcare Pharmacy stock. These financial firms have...

The future of Tübingen-based biotech firm CureVac hangs in the balance as the company approaches a critical juncture. With operational...

Stereotaxis shares gained 3.57% on Friday, closing at $2.32, but the real market-moving event arrives next week. Chief Executive Officer...

Xoma Royalty shares demonstrated positive momentum at the week's opening, trading at $32.14 and marking a nearly 1 percent gain....

After an extended period of decline, Pfizer's shares are attracting renewed attention from Wall Street. A powerful combination of regulatory...

Assembly Biosciences shares are demonstrating remarkable upward momentum, closing out the week with significant strength and positioning themselves for a...